Last reviewed · How we verify
CDobi
CDobi is a medication that works by inhibiting the activity of a specific enzyme.
CDobi is a medication that works by inhibiting the activity of a specific enzyme. Used for Type 2 diabetes, Hypertension.
At a glance
| Generic name | CDobi |
|---|---|
| Also known as | dobesilate |
| Sponsor | Services Hospital, Lahore |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | FDA-approved |
Mechanism of action
CDobi is a selective inhibitor of the enzyme responsible for a particular metabolic pathway. By blocking this enzyme, CDobi helps to reduce the levels of a certain substance in the body, which in turn helps to alleviate symptoms associated with its overproduction.
Approved indications
- Type 2 diabetes
- Hypertension
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Hypotension
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |